Functional characterization of α1 -adrenoceptor subtypes in vascular tissues using different experimental approaches:a comparative study
- 30 January 2003
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (2) , 359-368
- https://doi.org/10.1038/sj.bjp.0705033
Abstract
The α1-adrenergic responses of rat aorta and tail artery have been analysed measuring the contractility and the inositol phosphate (IP) formation induced by noradrenaline. Three antagonists, prazosin, 5-methylurapidil (α1A selective) and BMY 7378 (α1D selective) have been used in different experimental procedures. Noradrenaline possesses a greater potency inducing contraction and IP accumulation in aorta (pEC50-contraction=7.32±0.04; pEC50-IPs=6.03±0.08) than in the tail artery (pEC50-contraction=5.71±0.07; pEC50-IPs=5.51±0.10). Although the maximum contraction was similar in both tissues (Emax-tail=619.1±55.6 mg; Emax-aorta-698.2±40.8 mg), there were marked differences in the ability of these tissues to generate intracellular second messengers the tail artery being more efficient (Emax-tail=1060±147%; Emax-aorta=108.1±16.9%). Concentration response curves of noradrenaline in presence of antagonist together with concentration inhibition curves for antagonists added before (CICb) or after (CICa) noradrenaline-induced maximal response in Ca2+-containing or Ca2+-free medium have been performed. A comparative analysis of the different procedures as well as the mathematical approaches used in each case to calculate the antagonist potencies, were completed. The CICa was the simplest method to characterize the predominant α1-adrenoceptor subtype involved in the functional response of a tissue. In aorta, where constitutively active α1D-adrenoeptors are present, the use of different experimental procedures evidenced a complex equilibrium between α1D- and α1A-adrenoceptor subtypes. The appropriate management of LiCl in IP accumulation studies allowed us to reproduce the different experimental procedures performed in contractile experiments giving more technical possibilities to this methodology. British Journal of Pharmacology (2003) 138, 359–368. doi:10.1038/sj.bjp.0705033Keywords
This publication has 42 references indexed in Scilit:
- Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the α1-Adrenoceptor SubtypesMolecular Pharmacology, 2002
- Pathological role of a constitutively active population of α1D‐adrenoceptors in arteries of spontaneously hypertensive ratsBritish Journal of Pharmacology, 2002
- Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat‐1 fibroblasts stably expressing α1d‐adrenoceptorsFEBS Letters, 1999
- α1-Adrenoceptor subtypes and two receptor systems in vascular tissuesLife Sciences, 1998
- The 5-HT and α-Adrenoceptor Antagonist Effect of Four Benzylisoquinoline Alkaloids on Rat AortaJournal of Pharmacy and Pharmacology, 1998
- Pharmacological pleiotropism of the human recombinant α1A‐adrenoceptor: implications for α1‐adrenoceptor classificationBritish Journal of Pharmacology, 1997
- Pharmacological characterization of anα1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of ratBritish Journal of Pharmacology, 1997
- Pharmacological classification ofα1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aortaBritish Journal of Pharmacology, 1997
- The Cheng-Prusoff relationship: something lost in the translationTrends in Pharmacological Sciences, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973